Your browser does not support iframes.
Miami Herald Index
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Keryx Biopharmaceuticals, Inc.
(NQ:
KERX
)
7.940
USD
-0.100 (-1.24%)
Official Closing Price
/ Updated:
8:10 PM EDT, May 20, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
0
Open
8.090
Bid (Size)
7.580 (2000)
Ask (Size)
8.530 (600)
Prev. Close
8.040
Today's Range
7.905 - 8.260
52wk Range
1.500 - 9.980
Shares Outstanding
81,718,058
Dividend Yield
N/A
Top News
More News
Keryx Biopharmaceuticals Earnings Hindsight: Up 0.6% in Last 13 Days (KERX)
May 20, 2013
from
Comtex SmarTrend® News Briefs
UPDATE: Oppenheimer Raises PT on Keryx Biopharmaceuticals Following Management Meetings
May 17, 2013
In a report published Friday, Oppenheimer analyst Boris Peaker reiterated an Outperform rating on Keryx Biopharmaceuticals (NASDAQ: KERX ), and slightly raised the price target from $11.00 to $12.00....
Read More
category
Oppenheimer
,
KERX
,
Benzinga
, and 3 more.
from
Latest Articles from Benzinga.com
More News
Read More
KERX, ARIA, PDLI added to BioStock Watch List at GSR
May 14, 2013
from
ACCESSWIRE
Trading Alert for Keryx Biopharmaceuticals
May 13, 2013
from
AVAFIN
Keryx Biopharmaceuticals, Inc. (KERX) Posts Mixed Q1 Results
May 07, 2013
from
StreetInsider.com News Articles
Keryx Biopharmaceuticals, Inc. Announces First Quarter 2013 Financial Results
May 07, 2013
from
PR Newswire
Keryx Biopharmaceuticals, Inc. To Host Conference Call on First Quarter 2013 Financial Results
May 06, 2013
from
PR Newswire
Grab KERX 7.9% Cheaper Than Its Secondary?
May 02, 2013
category
Stocks
from
Market News Video
GSK, AZN, KERX, and RPTP Early Briefing and Review
May 02, 2013
from
ACCESSWIRE
Illumina and Other Bargain Biotech Stocks Worth a Look Now
May 01, 2013
category
SHPG
,
amgen
,
Benzinga
, and 31 more.
from
Latest Articles from Benzinga.com
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Your browser does not support iframes.
Your browser does not support iframes.